We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+24.01%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$55.5B
AUM Growth
+$14.2B
Cap. Flow
+$8.73B
Cap. Flow %
15.74%
Top 10 Hldgs %
91.2%
Holding
1,273
New
396
Increased
181
Reduced
191
Closed
434

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 0.25%
2 Communication Services 0.13%
3 Technology 0.08%
4 Healthcare 0.01%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
451
PUT
iShares Core S&P 500 ETF
IVV
$884B
$89.1K ﹤0.01%
200
-1,800
-90% -$759K
EMBK
452
CALL
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$88.9K ﹤0.01%
31,100
+30,100
+3,010% +$84.1K
SCLX icon
453
Scilex Holding
SCLX
$47.1M
$88.2K ﹤0.01%
+452
New +$125K
GRND icon
454
Grindr
GRND
$3.22B
$87.9K ﹤0.01%
+15,891
New +$96.7K
DLO icon
455
PUT
dLocal
DLO
$4.51B
$87.9K ﹤0.01%
+7,200
New +$95.2K
FIGS icon
456
CALL
FIGS
FIGS
$1.86B
$87.7K ﹤0.01%
+10,600
New +$80.6K
ERIC icon
457
Ericsson
ERIC
$32.9B
$87.4K ﹤0.01%
16,028
+2,808
+21% +$15.1K
XAR icon
458
PUT
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.15B
$85.1K ﹤0.01%
700
-800
-53% -$92.9K
HUT
459
CALL
Hut 8
HUT
$12.5B
$84.5K ﹤0.01%
+5,120
New +$52.5K
RVPH
460
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$84.4K ﹤0.01%
720
+545
+311% +$69.1K
MRVI icon
461
Maravai LifeSciences
MRVI
$951M
$84K ﹤0.01%
+6,755
New +$91.2K
ATEC icon
462
Alphatec Holdings
ATEC
$1.54B
$83.6K ﹤0.01%
+4,647
New +$72.4K
SOFI icon
463
CALL
SoFi Technologies
SOFI
$23B
$83.4K ﹤0.01%
+10,000
New +$65.2K
EOD
464
Allspring Global Dividend Opportunity Fund
EOD
$282M
$83K ﹤0.01%
19,082
+8,943
+88% +$38.2K
AMR icon
465
PUT
Alpha Metallurgical Resources
AMR
$1.8B
$82.2K ﹤0.01%
+500
New +$76.4K
VIOV icon
466
PUT
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.88B
$82.1K ﹤0.01%
1,000
-300
-23% -$23.7K
AKRO
467
DELISTED
Akero Therapeutics
AKRO
$82.1K ﹤0.01%
+1,758
New +$80.6K
VRCA icon
468
CALL
Verrica Pharmaceuticals
VRCA
$91.4M
$81.4K ﹤0.01%
1,410
-570
-29% -$34.6K
SIRI icon
469
SiriusXM
SIRI
$10.3B
$80.6K ﹤0.01%
+1,779
New +$67.2K
EVLV icon
470
CALL
Evolv Technologies
EVLV
$1.02B
$79.2K ﹤0.01%
13,200
+2,900
+28% +$13.7K
BB icon
471
BlackBerry
BB
$5.03B
$78.1K ﹤0.01%
14,130
+3,611
+34% +$17.5K
ACRS icon
472
PUT
Aclaris Therapeutics
ACRS
$739M
$77.8K ﹤0.01%
7,500
-29,300
-80% -$265K
LFCR icon
473
PUT
Lifecore Biomedical
LFCR
$168M
$77.4K ﹤0.01%
+8,000
New +$48.9K
ASTL icon
474
CALL
Algoma Steel
ASTL
$416M
$76.7K ﹤0.01%
+10,800
New +$80.2K
MCN
475
Madison Covered Call & Equity Strategy Fund
MCN
$118M
$76.4K ﹤0.01%
+10,329
New +$80.8K

Similar funds

Belvedere Trading's Q2 2023 Portfolio in Review

As of Q2 2023, Belvedere Trading held 1,273 positions worth $55.5B, up 34% from $41.3B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Belvedere Trading deployed $8.73B of net new capital in Q2 2023, opening 396 new positions and adding to 181 existing holdings. Its largest new stake was Amazon: 1,019,648 shares worth $133M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 0.25% of assets, up from 0.06% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Tesla, an estimated $21.9M trimmed.

  • Belvedere Trading's largest Q2 2023 buy was Amazon: 1,019,648 shares worth $133M.
  • Belvedere Trading added most to Apple in Q2 2023, an estimated $30.7M increase.
  • Belvedere Trading's biggest Q2 2023 reduction was Tesla, cutting an estimated $21.9M.
  • Belvedere Trading fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $117M.
  • Belvedere Trading's ten largest holdings make up 91% of its $55.5B portfolio in Q2 2023.
  • Belvedere Trading opened 396 new positions and closed 434 in Q2 2023.
  • Belvedere Trading's portfolio value rose 34% quarter-over-quarter to $55.5B.

Based on Belvedere Trading's 13F filing for Q2 2023, filed 8 Aug 2023.